Amoxicillin–clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial

BACKGROUND: Although amoxicillin–clavulanate is the recommended first-line empirical oral antibiotic treatment for non-severe exacerbations in children with bronchiectasis, azithromycin is also often prescribed for its convenient once-daily dosing. No randomised controlled trials involving acute exa...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Lancet
Glavni autori: Goyal, Vikas, Grimwood, Keith, Byrnes, Catherine A, Morris, Peter S, Masters, I Brent, Ware, Robert S, McCallum, Gabrielle B, Binks, Michael J, Marchant, Julie M, van Asperen, Peter, O'Grady, Kerry-Ann F, Champion, Anita, Buntain, Helen M, Petsky, Helen, Torzillo, Paul J, Chang, Anne B
Format: Artigo
Jezik:Inglês
Izdano: Elsevier Ltd. 2018
Teme:
Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7159066/
https://ncbi.nlm.nih.gov/pubmed/30241722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(18)31723-9
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items